"Clinical Hope" commemorates dogs diagnosed with terminal cancer who are undergoing clinical trials in order to minimize their pain and extend their lives. Cancer is one of the leading causes of deaths in dogs, and our canine companions fall prey to the same types of malignancies at relatively the same rate as humans. While the majority of cancer treatments for dogs derived from human oncology, this paradigm is quickly shifting thanks to revolutionary advances in canine cancer research. For example, "Pac-1" is an anti-cancer agent that was originally formulated for dogs and is now being translated to human cancer patients with aggressive malignant tumors.
In the new frontier of cancer therapies, humans' best friend continues to serve us by acting as an important model for progressive cancer therapies."Clinical Hope" commemorates dogs diagnosed with terminal cancer who are undergoing clinical trials in order to minimize their pain and extend their lives. Cancer is one of the leading causes of deaths in dogs, and our canine companions fall prey to the same types of malignancies at relatively the same rate as humans. While the majority of cancer treatments for dogs derived from human oncology, this paradigm is quickly shifting thanks to revolutionary advances in canine cancer research. For example, "Pac-1" is an anti-cancer agent that was originally formulated for dogs and is now being translated to human cancer patients with aggressive malignant tumors.
In the new frontier of cancer therapies, humans' best friend continues to serve us by acting as an important model for progressive cancer therapies.